Skip to content

Clinical trials

Phase 1/2 Endocrine Gland Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine Gland Neoplasms Phase: Phase 1/2 Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20173
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting2
Completed2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Hoffmann-La Roche1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine Gland Neoplasms5
Endocrine System Diseases5
Neoplasms5
Bronchial Neoplasms4
Carcinoma, Bronchogenic4
Carcinoma, Non-Small-Cell Lung4
Colonic Neoplasms4
Head and Neck Neoplasms4
Lung Diseases4
Lung Neoplasms4

Trials

Showing 76 to 5 of 5. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.